Detalles de la búsqueda
1.
FOXS1 is increased in liver fibrosis and regulates TGFß responsiveness and proliferation pathways in human hepatic stellate cells.
J Biol Chem
; 300(3): 105691, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38280429
2.
Glucocorticoid resistance remodels liver lipids and prompts lipogenesis, eicosanoid, and inflammatory pathways.
Prostaglandins Other Lipid Mediat
; 173: 106840, 2024 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-38830399
3.
Loss of hepatic PPARα in mice causes hypertension and cardiovascular disease.
Am J Physiol Regul Integr Comp Physiol
; 325(1): R81-R95, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37212551
4.
Bilirubin Levels Are Negatively Correlated with Adiposity in Obese Men and Women, and Its Catabolized Product, Urobilin, Is Positively Associated with Insulin Resistance.
Antioxidants (Basel)
; 12(1)2023 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36671031
5.
Suppressing Hepatic UGT1A1 Increases Plasma Bilirubin, Lowers Plasma Urobilin, Reorganizes Kinase Signaling Pathways and Lipid Species and Improves Fatty Liver Disease.
Biomolecules
; 13(2)2023 01 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36830621
6.
Bilirubin Nanoparticle Treatment in Obese Mice Inhibits Hepatic Ceramide Production and Remodels Liver Fat Content.
Metabolites
; 13(2)2023 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36837834
7.
Loss of Carnitine Palmitoyltransferase 1a Reduces Docosahexaenoic Acid-Containing Phospholipids and Drives Sexually Dimorphic Liver Disease in Mice.
bioRxiv
; 2023 Aug 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37645721
8.
Loss of carnitine palmitoyltransferase 1a reduces docosahexaenoic acid-containing phospholipids and drives sexually dimorphic liver disease in mice.
Mol Metab
; 78: 101815, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37797918
Resultados
1 -
8
de 8
1
Próxima >
>>